The lawyers at Saiontz & Kirk are now reviewing Dupixent cancer lawsuits for individuals diagnosed with cutaneous T-cell lymphoma (CTCL), Sézary syndrome, or other rare T-cell lymphomas after receiving Dupixent (dupilumab) injections for eczema, asthma, or related conditions. While Sanofi and Regeneron have promoted their drug… Read More
Amid growing evidence that establishes a link between Depo-Provera and meningioma side effects, lawsuits have been filed by women throughout the federal court system over the past year, each raising similar allegations that the drug makers failed to adequately warn about the potential risk of brain… Read More
It has been more than 18 months since federal regulators recalled Belviq due to a cancer risk associated with the diet drug. However, as new cases of Belvic cancer continue to emerge and individuals learn that previously diagnosed cancer may have resulted from side effects of… Read More
May 2024 Update: Following the settlement agreements reached in many Injectafer claims, new cases are no longer being accepted, and this content is provided for informational purposes only. The Injectafer FDA label was updated in February 2020 with new information about severe hypophosphatemia (HPP) risks. However,… Read More
April 2026 Update: Saiontz & Kirk is no longer filing new Elmiron lawsuits. This page is for informational and historical purposes only. As Elmiron lawsuits were previously filed by individuals diagnosed with a form of vision damage known as pigmentary maculopathy, former long-term users of the… Read More
April 2026 Update: Saiontz & Kirk is no longer filing new Elmiron lawsuits. This page is maintained for informational and historical purposes only. Elmiron lawsuits were previously filed nationwide by former users of the bladder drug who alleged they developed retina damage known as pigmentary maculopathy… Read More
April 2026 Update: Saiontz & Kirk is no longer filing new Elmiron lawsuits. This page is maintained for informational and historical purposes only. In prior years, a number of independent studies and case reports highlighted a potential link between Elmiron and eye problems, leading to lawsuits… Read More
April 2026 Update: Saiontz & Kirk is no longer filing new Elmiron lawsuits. This page is for informational and historical purposes only. The product liability lawyers at Saiontz & Kirk previously investigated potential lawsuits for users of the interstitial cytisis/bladder pain syndrome drug Elmiron, which may… Read More
Following concerns about whether side effects of ranitidine in Zantac increase the risk of cancer, the U.S. Food and Drug Administration (FDA) announced that all ranitidine-based drugs should be removed from the market, including name-brand Zantac, over-the-counter and all generic equivalents. (more…) Read More
